<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33443667</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Predictors of self-perceived health worsening over COVID-19 emergency in ALS.</ArticleTitle><Pagination><StartPage>1231</StartPage><EndPage>1236</EndPage><MedlinePgn>1231-1236</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-04997-z</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Factors influencing self-perceived health status over Corona Virus Disease 2019 (COVID-19) emergency in vulnerable populations, such as patients with chronic neurological diseases, are still unknown. In this work, we aimed at testing whether clinical care changes imposed by the quarantine, together with certain demographic and disease-specific features, might have determined a self-perceived worsening of health status in patients with amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A brief web-based questionnaire investigating self-perceived anxiety, depression, and motor worsening, as well as clinical care changes over COVID-19 emergency, was administered to ALS patients currently followed at San Martino Hospital. Ordinal and logistic regression analyses were applied to identify significant predictors of health status.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-seven ALS patients completed the questionnaire. A total of 35.08% of cases reported anxiety symptoms, 36.84% depressive symptoms, and 35.08% reported worsening of motor symptoms. Significant predictors of anxiety symptoms severity included female gender, greater motor impairment, more aggressive disease course, and rehabilitation therapy suspension. The only significant predictor of depressive symptoms severity was a more aggressive disease course. Significant predictors of motor worsening were shorter disease duration and exams/visits cancelation.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">COVID-19 emergency and its management exerted a significant impact on self-perceived health status in patients with ALS, particularly in those cases in the earliest disease phases and with a more aggressive disease course. These findings have potential to improve personalized medicine strategies in the next phase.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cabona</LastName><ForeName>Corrado</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4282-8805</Identifier><AffiliationInfo><Affiliation>Division of Clinical Neurophysiology and Epilepsy Center, Ospedale Policlinico San Martino, IRCCS, Largo R. Benzi 10, 16132, Genoa, Italy. corrado.cabona@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraro</LastName><ForeName>Pilar M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roccatagliata</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schenone</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inglese</LastName><ForeName>Matilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villani</LastName><ForeName>Flavio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Clinical Neurophysiology and Epilepsy Center, Ospedale Policlinico San Martino, IRCCS, Largo R. Benzi 10, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caponnetto</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="Y">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012649" MajorTopicYN="Y">Self Concept</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Corona virus disease 2019</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Motor worsening</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>14</Day><Hour>12</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33443667</ArticleId><ArticleId IdType="pmc">PMC7807220</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-04997-z</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-04997-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323:1775&#x2013;1776.</Citation><ArticleIdList><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Manji H, Carr AS, Browlee WJ, Lunn MP. Neurology in the time of covid-19. J Neurol Neurosurg Psychiatry. 2020;91:568&#x2013;570. doi: 10.1136/jnnp-2020-323414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323414</ArticleId><ArticleId IdType="pubmed">32312872</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, Mazzini L, Mora G, PARALS study group Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82(7):740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, Willey E, Ampong MA, Ellis CM, Shaw CE, al-Chalabi A, Leigh PN. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72(12):1087&#x2013;1094. doi: 10.1212/01.wnl.0000345041.83406.a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000345041.83406.a2</ArticleId><ArticleId IdType="pmc">PMC2821838</ArticleId><ArticleId IdType="pubmed">19307543</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J Neurol Sci. 1999;169(1-2):13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lucia N, Ausiello FP, Spisto M, Manganelli F, Salvatore E, Dubbioso R. The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness. Neurol Sci. 2020;41(9):2339&#x2013;2341. doi: 10.1007/s10072-020-04592-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04592-2</ArticleId><ArticleId IdType="pmc">PMC7359442</ArticleId><ArticleId IdType="pubmed">32666406</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui F, Zhu W, Zhou Z, Ren Y, Li Y, Li M, Huo Y, Huang X. Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease. Neuropsychiatr Dis Treat. 2015;11:2847&#x2013;2854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639547</ArticleId><ArticleId IdType="pubmed">26604769</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zdin S, Bayrak &#xd6;zdin &#x15e;. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender. Int J Soc Psychiat. 2020;66(5):504&#x2013;511. doi: 10.1177/0020764020927051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020764020927051</ArticleId><ArticleId IdType="pmc">PMC7405629</ArticleId><ArticleId IdType="pubmed">32380879</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsson Larsson B, Ozanne AG, Nordin K, Nygren I. A prospective study of quality of life in amyotrophic lateral sclerosis patients. Acta Neurol Scand. 2017;136(6):631&#x2013;638. doi: 10.1111/ane.12774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12774</ArticleId><ArticleId IdType="pubmed">28523721</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, Steinbach R, Witte OW, Grosskreutz J. Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis. eNeurologicalSci. 2019;16:100. doi: 10.1016/j.ensci.2019.100198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2019.100198</ArticleId><ArticleId IdType="pmc">PMC6661459</ArticleId><ArticleId IdType="pubmed">31384673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillemacher T, Gr&#xe4;ssel E, Tigges S, Bleich S, Neund&#xf6;rfer B, Kornhuber J, et al. Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(4):245&#x2013;249. doi: 10.1080/14660820410021294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820410021294</ArticleId><ArticleId IdType="pubmed">15799555</ArticleId></ArticleIdList></Reference><Reference><Citation>Edge R, Mills R, Tennant A, Diggle PJ, Young CA, TONiC study group Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature. J Neurol. 2020;267(3):607&#x2013;615. doi: 10.1007/s00415-019-09615-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09615-3</ArticleId><ArticleId IdType="pmc">PMC7035222</ArticleId><ArticleId IdType="pubmed">31696295</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews JA, Berry JD, Baloh RH, Carberry N, Cudkowicz ME, Dedi B, et al. Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: challenges and opportunities. Muscle Nerve. 2020;62(2):1. doi: 10.1002/mus.26989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26989</ArticleId><ArticleId IdType="pmc">PMC7283687</ArticleId><ArticleId IdType="pubmed">32445195</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Telesca A, Dalla Bella E, Bersano E, Lauria G. Amyotrophic lateral sclerosis patients' and caregivers' distress and loneliness during COVID-19 lockdown. J Neurol. 2020;21:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7372539</ArticleId><ArticleId IdType="pubmed">32696342</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Cantello R, Ambrosini S, Mazzini L, CANPALS Study Group Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19. Neurol Sci. 2020;41(6):1365&#x2013;1367. doi: 10.1007/s10072-020-04457-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04457-8</ArticleId><ArticleId IdType="pmc">PMC7240164</ArticleId><ArticleId IdType="pubmed">32440978</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombaci A, Abbadessa G, Trojsi F, Leocani L, Bonavita S, Lavorgna L, Digital Technologies, Web and Social Media Study Group of the Italian Society of Neurology Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail. Neurol Sci. 2020;6:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538170</ArticleId><ArticleId IdType="pubmed">33025327</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R, Moglia C, D'Ovidio F, Di Pede F, De Mattei F, Cabras S, et al. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotroph Lateral Scler Frontotemporal Degener. 2020;12:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32924624</ArticleId></ArticleIdList></Reference><Reference><Citation>Capozzo R, Zoccolella S, Musio M, Barone R, Accogli M, Logroscino G. Telemedicine is a useful tool to deliver care to patients with amyotrophic lateral sclerosis during COVID-19 pandemic: results from southern Italy. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(7&#x2013;8):542&#x2013;548. doi: 10.1080/21678421.2020.1773502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1773502</ArticleId><ArticleId IdType="pubmed">32530314</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>